In vitro studies of Chlamydia trachomatis susceptibility and resistance to rifampin and rifabutin
- 1 August 1989
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 33 (8), 1393-1394
- https://doi.org/10.1128/aac.33.8.1393
Abstract
Although rapid emergence of antibiotic-resistant mutants of Chlamydia trachomatis occurs when the organism is grown in subinhibitory concentrations of rifampin, no such mutants could be demonstrated when the organism was propagated under the same conditions in subinhibitory levels of the related drug rifabutin.This publication has 7 references indexed in Scilit:
- Sensitivity of mitomycin-C treated McCoy cells for isolation ofChlamydia trachomatis from genital specimensEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987
- Enzyme-linked immunosorbent assay for the in-vitro detection of sensitivity of Chlamydia trachomatis to antimicrobial drugsJournal of Antimicrobial Chemotherapy, 1987
- INVITRO SUSCEPTIBILITY OF MYCOBACTERIUM-AVIUM COMPLEX AND MYCOBACTERIUM-TUBERCULOSIS STRAINS TO A SPIRO-PIPERIDYL RIFAMYCINPublished by Elsevier ,1982
- Prediction of Efficacy of Antimicrobial Agents in Treatment of Infections Due to Chlamydia trachomatisThe Journal of Infectious Diseases, 1978
- Rifampicin, an antitrachoma antibiotic.1972
- Rifampicin—A New Antitrachoma DrugNature, 1969